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Hazardous Drug Administration in the Home: Reducing Exposure Risks 
A serious health threat may be looming over patients and families fighting cancer as 
antineoplastic drug administration shifts from conventional healthcare centers to the home 
setting.  Without safe handling, storage, and proper waste disposal, hazardous drug (HD) 
residues can expose not only family members, but also visitors and the environment (Crickman 
& Finnell, 2016).  Hazardous drug exposure can potentially alter DNA, impose reproductive 
harm, and is toxic to the body’s natural defenses.  According to Graeve, McGovern, Arnold and 
Polovich (2017), toxic residues may cause acute allergic reactions and other unintended adverse 
side effects to caregivers. 
Widespread hazardous drug exposure in the home setting has been well-documented 
through many years of studying chemotherapy patients and families (Bohlandt, Sverdel, & 
Schierl, 2017; Connor, Zock, & Snow, 2016; Rudnitzki & McMahon, 2015; Yuki, Ishida, & 
Sekine, 2015).  However, safeguards to prevent home residue exposure are lagging, and patient 
and family safety in the home remains unmonitored and less understood (Carpenter, Famolaro, 
Hassell, Reefer, Robins, & Siegel, 2017).  Contributing to the shift in hazardous drug 
administration include the rising numbers of patients receiving oral chemotherapy (Polovich & 
Olsen, 2018).  Oral chemotherapy is effective and may be considered a more desirable route by 
patients over other similar cancer treatment options, but these drugs require the same safe 
handling as HDs in other formulations (Lester, 2012).   
This large not-for-profit home care agency is located in Northern California and is an 
extension of a large hospital system serving the Sacramento region. Services include home 
health, palliative care, hospice care, and infusion (IV) therapy.  The microsystem provides short-
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term acute and chronic disease management for patients recently discharged from a hospital for a 
myriad of health issues. The project will focus on providing home care nurses with the training 
and tools required to minimize personal exposure to hazardous drugs in a home setting.  
The home health care (HHC) industry is adjusting to the influx of patients receiving oral 
and IV hazardous drug agents in the home and recognize the growing need to address employee 
occupational safety and health risks. The population in this microsystem include patients who are 
receiving infusion therapies such as antibiotics, blood products, chemotherapy, total parenteral 
nutrition (TPN), hydration, inotropes, and intravenous pain management.  Cancer patients may 
require some or all of these infusions during the course of cancer treatment. Oral chemotherapy 
adds to the complexity of caring for patients who have additional comorbidities that complicate 
care. Home care infusion nurses are struggling to comprehend the importance of their increasing 
role and responsibility regarding HD identification, education, and personal safety precautions 
required for themselves and families of cancer patients. 
The team consists of one team leader, two home infusion coordinators, and 10 to 12 
registered nurses.  Each nurse has a caseload of up to 20 patients, visiting four to five patients per 
day.  Six nurses are Certified Registered Nurses in Infusion Therapy (CRNI). Nursing experience 
ranges from 4 years to 25 years. The average patient census for the team ranges from 100 to 150, 
and the average patient age ranges from 45 to 75 years. 
Clinical Leadership Theme 
 The project aims to improve the confidence, competence, and compliance of home care 
nurses’ use of personal protective equipment (PPE) when administering HDs in the home. The 
clinical nurse leadership theme that correlates to this project is safety with HD PPE practice. 
According to the American Association of Colleges of Nursing (2013), the CNL role of 
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“Educator” uses the most current, evidence-based research to teach those persons within the 
microsystem. The CNL role of “Systems Analyst/Risk Anticipator” monitors the microsystem’s 
operations in order to anticipate potential problems and make corrections to improve processes 
that put nurses and families at risk. 
Statement of the Problem 
   The U.S. Bureau of Labor Statistics (2015) reported over eight million health care 
workers in the United States are potentially exposed to HD residues, emphasizing current safe 
handling precautions and oversight are inadequate.  Safe-handling procedures were structured for 
application in controlled healthcare environments and are sometimes not realistic in the home 
setting.  The commonality is that both settings struggle with environmental exposure, non-
compliance with PPE, and waste disposal practices (He, Mendelsohn-Victor, McCullagh, & 
Friese, 2017).  In response to increasing pressures from healthcare professionals, the U.S. 
Pharmacopeia Convention (USP, [2016]) General Chapter <800> Standards for hazardous drug 
handling and enforcement were developed and will be enforced beginning December 1, 2019.  
The standards will require all health care organizations to have hazardous drug management 
programs in place or suffer imposed fines or suspended licensure consequences.  
          Little emphasis has been placed on self-protection strategies for nurses in the home setting, 
and most are unaware of the increasing dangers of exposure. One major concern is the 
unavailability of hazardous drug PPE for home care nurses. Other issues include (1) fragmented 
patient health information, (2) incomplete medication records, (3) work productivity pressures, 
(4) and outdated policies. Evidence-based HD education and innovative learning activities are 
lacking because of budgetary constraints and access to oncology content experts. However, safe 
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drug handling should be a top priority because any level of HD exposure is unacceptable 
(Diamond, 2017). 
Project Overview 
Safety and advocacy are important core values of the CNL’s role and are the basis for this 
evidence-based project. With organizational support, home care nurses will become better safety 
advocates, not only for patients and families, but for their colleagues that follow.  The CNL’s 
objectives aim to (1) improve nurses’ knowledge of hazardous drugs, (2) improve compliance 
with PPE use in the home, (3) provide nurses with HD PPE and (4) develop a quick reference 
guide for reporting an exposure. Finally, a “Hazardous Drug Safe Handling Guide” for patients 
and families will describe actions to minimize personal and home exposure.   
To accomplish best practices, the global project aims to improve safe handling from 39% 
to 95% by implementing two home care nurse educational sessions; (1) recognizing and 
responding to HD exposure in the home, and (2) providing a hands-on PPE competency training 
no later than March 15, 2018. The specific aim is aligned with the global aim of providing a 
residue-free home environment for everyone.  The global and specific aims are united and both 
create a sense of urgency with a definite purpose, expected outcomes, and time frame for 
sustaining results. 
The project begins with (1) surveying home care nurses to determine knowledge, beliefs, 
and attitudes about hazardous drug exposure risks, and (2) understanding current comfort levels 
and experience with personal protective equipment (PPE), with the aim of minimizing hazardous 
drug exposure during a home visit. The process ends with enhanced organizational support for 
home care nurses by providing HD education and supplying the necessary PPE by March 15, 
2018.  It is important to work on this project now because the known adverse health and 
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environmental risks are valid, and new hazardous drug regulations mandate and support an 
efficient, standardized approach. 
Methodology 
The organization uses a performance improvement real-time data collection program 
called Strategic Healthcare Programs (SHP). This program provides analytics, benchmarks, and 
dashboards for home care agencies across the country.  The data collection is intended as a guide 
to help improve quality and optimize performance for home health care agencies, hospices and 
home infusion pharmacies.  The data also helps the organization maximize reimbursement for 
patient care and helps improve compliance with the Centers for Medicare and Medicaid (CMS) 
requirements specific to home health care participation.  This program is a good resource for 
CNL’s because SHP reports highlight areas where staff education and professional oversight 
should be focused to improve patient satisfaction and health outcome scores. 
Strategic Health Programs (SHP) data identified that from January 1, 2017 through 
December 2017, 440 patients were admitted with a primary or secondary cancer diagnosis to the 
microsystem.  However, data mining for information was cumbersome and incomplete in 
determining the current census of patients receiving hazardous drugs.  Without the ability to 
accurately identify patients on service who are prescribed these medications, the risk of exposure 
is even more alarming.  More work needs to be done with internal and external informatics 
specialists to capture this population’s data, perhaps through specific ICD-10 coding or HD 
medication list alerts in the future. 
Rationale  
Several methods of evaluating information to identify the specific needs of the project 
included (1) performing a root cause analysis, (2) home care nurse surveys at the annual skills 
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day competency fair, and (3) completing a SWOT (Strengths, Weaknesses, Opportunities, and 
Threats) analysis.  The root cause analysis (see Appendix A) identified outdated policies 
addressing HD management, inadequate and unavailable PPE, and a lack of evidence-based 
resources to support clinicians in teaching families how to minimize exposure with HD 
administration.   
The nurse surveys from the competency fair in January 2018 provided good data on 
several fronts (see Appendix B).  When nurses were asked about the risks associated with 
hazardous drug administration to test for “knowledge of the hazard”, 25% felt that oral 
chemotherapy was safer to administer than other routes.  Fifty-one percent of nurses perceived 
personal home exposure risks as highly likely, but over 30% felt it was unlikely. When 
evaluating workplace safety, 79% of nurses assumed that the organization had a HD policy 
which was not the case (see Appendix B). 
When assessing knowledge and experience with PPE use in the home, 75% of nurses 
admitted to having little to none. Nurses expressed hesitation to don PPE because it may cause 
patient or family anxiety. Nurses rationalized that it would take longer to don PPE than it would 
to “hand a pill to the patient”.  While this may be true, unsafe handling place everyone at risk and 
sets the stage for potential adverse results. With new advances in science and technology, 
patients are performing tasks originally done by trained nurses. However, it does not negate the 
responsibility of nurses to supervise and support patients performing those tasks.  
The SWOT analysis (see Appendix C) clarified the overwhelming need for the 
organization to address HD exposure now to prepare for upcoming enforceable worker 
protection regulations by federal, CMS, state and other credentialing entities expected in 2019. 
The analysis also highlighted the weaknesses and vulnerabilities of home care clinicians in 
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regards to the lack of knowledge about antineoplastic administration and the beliefs that 
exposure risks were low or non-existent in the home setting.  Other weaknesses identified were 
operational issues with informatics and application software used by nurses to access and 
document patient care.  Opportunities to improve family and home care nurse safety through the 
application of best practices with safe handling and PPE use are within reach and are worthy 
goals of this CNL project. 
Cost Analysis 
The project required a solid organizational hazardous drug program framework that was 
missing. As a consequence, it took the senior management team six months to initiate a few 
temporary fixes to protect nurses until a comprehensive HD program could be implemented. 
Portions of the USP <800> Standards were chosen as the developing framework in the 
microsystem (see Appendix D).  Budget projections (see Appendix E) lists the items and 
estimates required to comply with those standards. A CNL will be essential in developing each 
piece of the framework to ensure effective use of resources and minimize costs. It will take 12 
months for the program to be fully integrated into the microsystem.  After the program is fully 
sustainable, the CNL could refocus on other important safety and quality issues.  
An education module would be added to new hire and annual competency training 
through the “HealthStream” on-line learning system. A customized PPE kit would be available in 
the office for nursing to obtain for patients requiring these items.  A personal PPE kit for car 
stock would cost the organization around $16.00 per nurse, however, individual items such as 
gloves and plastic-backed pads, could be restocked separately. The overall costs over two years 
is around $300,000.  By implementing competency training and providing PPE, this project will 
improve the safety of nurses and families by 95% no later than March 30, 2018.   
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The risk to the organization will also be reduced in regards to occupational health claims 
due to HD exposure.  According to the Worker’s Compensation Insurance Rating Board, the 
2017 average California indemnity claim averaged $37, 054 which was the 5th highest-reported 
claims cost in the United States (WCIRB, 2017). This average claim is 40% higher than the 
median average nationwide. With this cost risk in mind, and applying it to ten exposed nurses, 
the cost for one year would be over $370,540 per year. The average California claim is reported 
as paid over three years at a cost of $1.1 million dollars for 10 potential nurse exposures. 
Change Theory 
Kotter’s change theory will be used to implement an evidence-based quality improvement 
project that addresses HD safety for home care nurses as described in Appendix F (Kotter & 
Cohen, 2002).  The model was chosen because it intends to promote behavioral change (Frieson, 
Foote, & Wagner, 2012). The 8-step model will help the microsystem and organization complete 
the changes necessary to provide nurses, and patients and families, with a safer work and home 
environment with hazardous drug administration.  This is the perfect time to implement this 
project because healthcare organizations are preparing for the 2019 enforcement deadline, and 
home care agencies will not be exempt from the USP <800> Standards and regulations outlined 
for patient and worker safety. 
Kotter’s 8-step change theory stresses when people connect emotions with a desired 
change, the change is more apt to be effective and sustainable. With improved knowledge and 
awareness of exposure hazards, nurses are more apt to practice safe handling to protect 
themselves, patients and families.  The steps to accomplish the desired change include; (1) 
assuring everyone understands the sense of urgency, (2) forming a powerful, interdisciplinary, 
guiding coalition, (3) creating a common vision, (4) communicating the vision of what the future 
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would look like, (5) empowering others to share the vision, (6) planning for, and creating short-
term wins that create momentum, (7) removing the negative resistance, not letting up, and (8) 
making it stick.  
Data Source/Literature Review 
The PICO statement used to find literature to support the project was “With the 
increasing risk of HD exposure to (P) home care nurses, patients and families, and the 
environment, what is the effect of a (I) hands-on PPE nursing in-service compared to (C) no in-
service on the level of (O) nursing compliance with PPE use?”  Key words for the PICO question 
included hazardous drug, health care workers, personal protective equipment, safe-handling, and 
chemotherapy. Numerous articles were available to support the PICO question regarding 
healthcare workers (those employed in controlled-health settings) but few specific to home care 
workers.   
After careful literature review, and advanced searches in CINAHL and PubMed 
databases, 11 articles with dates that ranged from 2012 to 2017 were selected for review. The 
articles in the review were evaluated for evidence and quality using the Johns Hopkins Nursing 
Evidence-Based practice tool. Four of the 11 articles chosen were rated Level IV and good 
quality. The results of the studies selected provided consistent evidence related to HD exposure 
risks and PPE requirements. The strengths and limitations of the Level IV literature indicated the 
need for further research on home environmental contamination and long-term health effects 
with chronic residue exposure. 
Bohlandt, Sverdel, and Schierl (2017) conducted an environmental and biological study 
with the aim of confirming HD residues on common household surfaces inside 13 homes of 
ambulatory patients receiving outpatient chemotherapy and determine whether HD levels could 
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be detected in the urine of persons residing in the home.  There were 13 study participants who 
received intravenous chemotherapy in an outpatient clinic.  Two-hundred and sixty-five wipe test 
samples were taken from home surfaces, including toilet, bathroom, and kitchen, and 62 urine 
specimens from patients and families were collected.  Every surface tested had significant levels 
of HD residues.  However, there were no traceable residues found in the urine of family 
members. This research study concluded that strict hand hygiene measures and PPE are 
necessary to ensure a safer home environment, free from hazardous drug residues. The research 
also confirmed that the patient’s urine post-chemotherapy was the main source of contamination 
inside the home. The evidence presented in the article was a Level IV and of good quality. 
Another study by Yuki, Ishida, and Sekine (2015) measured urinary hazardous drug 
excretion by patients and family members at home. Eight patients treated with 
cyclophosphamide (CP), 10 family members, and ten control patients provided urine samples 
over seven days. One hundred twelve of 276 urine samples from patients detected CP five days 
after treatment. Fifty-two of 243 urine specimens from family members had detectable levels of 
CP.  The long-term effects of low-dose HD exposure are not well-understood. Furthermore, the 
researchers stressed the need to develop consistent home safety measures to protect patients and 
families. Even though the study was limited in size, the results were significant and confirmed 
through scientific analysis. The evidence presented was also a Level IV and of good quality. 
Eisenberg (2015) argued the need to change workplace culture regarding HD safety 
precautions, implement current guidelines, and resolve misunderstandings that exposure risks are 
minimal.  The author asserts that current guidelines and research to support stronger prevention 
programs, including enforcement, will lead to better results.  The USP <800> Standards were 
reviewed as it relates to state legislative involvement and The Joint Commission (TJC) 
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enforcement implications on healthcare organizations, however, home care enforcement was not 
mentioned.   
Dike, Ogunmakin, Pokluda, Shank, Yates, and Payne (2014) argue that while home HD 
self- administration might be convenient for patients and families, these drugs require the same 
safe handling to avoid secondary exposure. Home care nurses will require PPE and access to 
chemotherapy spill kits.  However, kits may need to be modified to apply to some unique home 
exposure situations.  The CNL project has addressed this issue and intends to ensure that nurses 
have the proper PPE and training necessary to provide better barrier protection and safer care. 
An international pharmacy panel collaboratively acknowledged the increase in oral 
chemotherapy practices and the issues surrounding safe handling and waste disposal of toxic 
medications outside of a controlled environment.  Patients and families are now preparing and 
administering HDs and potential exposure risks have increased.  The panel expressed concerns 
that the attitudes and beliefs of healthcare workers may influence the behaviors of families by 
downplaying exposure risk to oral HDs by indicating that personal protection is unnecessary.  
International roundtables led to discussions about storage, handling, patient and worker safety, 
and the need to standardize practices specific to each organization’s need to protect healthcare 
workers and the public (Goodin, Griffith, Chen, Chuk, Daouphars, Doreau, C., . . . Meier, 2011).   
Likewise, Lester (2012) provided an overview of evidenced-based literature that supports 
the importance of ensuring that all healthcare workers are educated on applying the same 
principles of HD management with oral agents as with other methods of administration.  The 
author recommended that healthcare workers should be instructed to monitor patients for 
adherence and compliance to safe administration practices to ensure they receive the optimal 
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benefits. The author recommended that proper education and competencies with PPE include 
patients and families. 
Rudnitzki and McMahon (2015) conducted a systematic review of the literature from 
2003 to 2014 with the aim of understanding the implications for nursing practice related to the 
shift in responsibility to patients and families regarding hazardous drug administration.  
Unintentional exposure to family members, medication errors, and unaddressed toxicity concerns 
and environmental pollution were among some of the identified risks associated with HD self-
administration without professional oversight.  The false impression of safety with oral 
chemotherapy versus intravenous routes indicates that patients may not understand the potential 
hazards of oral hazardous drugs.  Overall, the authors’ review confirmed patient education and 
training were essential to ensure the safety of others. 
One prospective-controlled study compared routine instruction to innovative instruction 
in nursing students and discovered that more knowledge and practical application skills were 
acquired and retained better using an innovative teaching approach.  The researchers found that 
nursing students lacked understanding that oral chemotherapy was as dangerous as other routes 
of HDs and were less inclined to use PPE during administration. A decrease in environmental 
contamination was a result of improving nurses’ understanding and skills. When considering the 
best method for instruction, this study revealed innovative instruction could be applied to this 
project (Zimmer, Hartl, Standfuls, Mohn, Bertsche, Frontini, . . . Bersche, 2016). 
Crickman and Finnell’s (2015) literature review asserts healthcare workers in multiple 
settings may be at risk for HD residue exposure that could lead to adverse health consequences.  
Evidence-based PPE and safe-handling recommendations were presented acknowledging 
modifications would have to be considered for the home setting. Recommendations ranged from 
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improving PPE competency and access, increasing professional oversight and medical 
monitoring, standardizing HD identification processes, and implementing a comprehensive HD 
program for all home care workers.  
Hennessy and Dynan (2014) reported on a PPE initiative conducted at Dana-Farber 
Cancer Institute in the ambulatory infusion center. Observations of oncology infusion nurses 
revealed a 30-40% compliance rate with PPE use while caring for patients. The project used the 
framework for the Model for Improvement which is a continuous process of testing change, 
assessing performance, and providing feedback. The importance of this observational study is 
that compliance dramatically improved by implementing staff audits, peer review and innovative 
learning activities. 
The CNL project includes mandatory in-services to improve knowledge and awareness of 
HD safety. The process consists of observations of individual nurse competency and compliance 
with PPE standards, immediate feedback to encourage best practices, and real-time measurable 
performance postings.  A safe handling awareness campaign along with conscience raising 
activities (lectures and interdisciplinary discussions) will hope to improve PPE competency and 
compliance to 95%.  Kotter’s change theory will incorporate much of what was done to improve 
and sustain the Dana-Farber initiative, as it is more relevant to this project. 
Timeline 
The project will be completed in phases. “Phase 1” began in September 2017 and will 
conclude in April, 2018, however, future phases will continue within the organization through 
December 1, 2019 to ensure compliance with the USP <800> Standards. Senior leadership 
recognized the need to begin the project in September 2017.  From September 2017 to December 
15, 2017, organizational processes such as policy review and revisions, education module 
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program development, and home PPE items were agreed upon. The Gantt chart (Appendix G) 
defined a step-by-step timeline to complete this phase, however, for the purposes of this project, 
the timeline began on January 15, 2018 and will end on April 6, 2018. 
The first step began with providing an initial survey of 61 homecare and infusion team 
(HIT) nurses at the annual skills day competency fair on January 15th, 2018. The purpose of the 
survey was to gather data to determine current knowledge, beliefs, attitudes, and behaviors 
associated with HD precautions and administration, and on January 16th, the data was reviewed. 
Second, a team of oncology nurses began developing several health literacy tools that included 
an HD oral administration protocol from January 20st through February 25th. The Oncology 
Certified Nurse (OCN) worked with the team as a content expert for the home health division to 
create a “Hazardous Drug Home Safety Guide” (see Appendix H) for families and a “Quick PPE 
Choice Guide” (see Appendix I) for home care clinicians.  Third, a nursing in-service with half 
of the home infusion team was done on personal protective equipment training on March 3rd.  
Fourth, a home visit was completed with a nurse on March 6th.  Fifth, a second in-service was 
completed on March 15th with the other half of the nurses.  Again, a home visit was arranged 
with a nurse on March18th. Sixth, the microsystem was rewarded for its contribution to 
developing a culture of safety in the patients’ homes. Seventh, the results were shared with both 
nursing groups on March 30th.  Eighth, results for phase 1 will be presented to senior leadership 
with recommendations to include all homecare divisions in future plans. 
Expected Results 
With the implementation of a hazardous drug administration program, the leadership 
team expects the organization will be compliant with the USP <800> Standards ahead of the 
projected mandate of December 1, 2019. Home care clinicians will be more competent and 
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inclined to practice safe handling and waste disposal. Personal protection strategies will improve 
as 95% of homecare nurses will utilize proper PPE when exposure risk is present. Survey results 
from the annual skills day held in January 2018 will be compared to survey results on March 30th 
when the nurses regroup, and data will be compared to see if improvements have been realized.  
Providing nurses with the education and training with PPE will improve safe handling of 
HDs in the home. In addition to improving safety, an HD kit will ultimately be more cost-
effective to the organization as nurses will be protected from toxic exposure.  Patients and 
caregivers will feel more confident in managing potential HD spills. The success of this change 
process affirms efficient lateral integration and improved patient-nurse partnerships that promote 
safe patient-centered care for those requiring hazardous drug administration at home. 
As more evidence becomes available on the acute and long-term effects of HD exposure 
in the home, nurses will need to take a more proactive approach in reviewing the institutional 
policies and workplace environment to ensure feasible evidence-based solutions.  Themes that 
may emerge from this project include (1) tracking exposed healthcare workers through an 
organizational database that is reportable to OSHA, and (2) increasing efforts to enforce 
regulations at every level of government.  According to Polovich and Olsen (2018), thirty years 
of studying the issue has not solved the problem of occupational HD exposure.  
Nursing Relevance 
The unique nature of providing hazardous drug administration to patients in the home has 
posed a new dilemma; keeping clinicians, patients and families, and the environment safe.  The 
recommendations for safe-handling have remained consistent through the years, nonetheless, 
suboptimal PPE use and HD exposure continue to plague the workplace. The home environment 
is more complex for HD administration because each home has its own limitations.  Personal 
Running Head: HAZARDOUS DRUG ADMINISTRATION 
 
17 
protective equipment, including the recommended type of gloves for oral administration, have 
not been available to homecare nurses. This issue underscored the need for organizations to 
standardize PPE and ensure nurses are protected when providing patient care in the home. 
Furthermore, the Occupational Safety and Health Administration (OSHA) recommends 
using a hierarchy of controls to address potential hazardous drug exposures (see Appendix J). 
Some of the controls are not feasible in the home. For example, the first control in the hierarchy 
is eliminating the source. Patients are prescribed these medications to treat disease, thus, 
elimination is impossible.  The second control is to replace the HD with an alternative. This too, 
would have to be the physician’s decision.  The third control would be to isolate persons from the 
hazard. This can be done in the home by limiting the number of persons assisting the patient with 
drug administration.  Nurses could instruct the patient to store and administer the agent in one 
area of the home to avoid cross-contamination to surfaces in the home setting.  The fourth 
control, “changing the way people work”, is an important and practical solution because nurses 
can educate and train patients and caregivers to practice good hand hygiene before and after 
administration, how to clean-up exposed areas, dispose of hazardous waste, and reporting of 
personal contact with agents that have the potential to cause adverse acute and long-term side 
effects.  The final control in the hierarchy includes protecting workers and families by using 
barriers and PPE.  This critical step minimizes risks associated with contact.  However, PPE 
needs to be readily available not only for clinicians, but for families too. 
Summary Report 
The aim of this evidence-based project “Hazardous Drug Administration in the Home: 
Reducing Exposure Risks” was to improve home care nurses’ knowledge and competency 
regarding hazardous drug administration and the use of personal protective equipment (PPE) in a 
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home setting.  The project began in January 2018 and continued through April 6, 2018 in a home 
health microsystem of a large community hospital system.  The expectations after didactic and 
hands-on demonstration sessions geared toward nurses proposed to increase knowledge and 
competence from 39% in January 2018 to 95% in April 2015. However, management only 
allowed 15 of the 61 homecare nurses to participate in the project. After instruction, only 10 of 
15 home infusion nurses expressed comfort with using a chemotherapy spill kit, and 11 of 15 
stated they were now familiar with the steps involved in managing a chemotherapy exposure in 
the home setting. It is clear that home care nurses will need joint supervisory visits and regular 
PPE competency training over time to reach the goal of 95% compliance with PPE. A Hazardous 
Drug Administration Safe Handling Checklist will be needed to document initial and annual 
compliance, and competency tracking (see Appendix H). 
Methods and teaching aides used to implement the project were (1) a power point 
presentation on hazardous drug administration, (2) hands-on PPE training session, (3) hazardous 
drug administration checklist for clinicians, (4) quick PPE choice guide for clinicians and (5) a 
patient and family tool about hazardous drug safety in the home.  All of the tools were developed 
by the CNL student with the assistance of a health literacy team, oncology nurse experts, and 
interprofessional collaboration between hospital nurses, oncology clinic nurses, outpatient and 
home infusion pharmacists, and the home health care nursing team.  The Chief Nurse Executive 
(CNE) was instrumental in streamlining communication with the various home health directors 
who provided guidance that influenced the outcomes of the project. However, this expanded the 
project well beyond the plans associated with this phase of implementation. 
The baseline data collected through nurse questionnaires provided opportunities for 
future improvement projects within the microsystem.  The data also revealed a serious gap in 
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knowledge that places homecare nurses, patients and families, and the environment at risk for 
HD exposure.  Kotter’s 8-step change theory provided a methodical approach to completing a 
small piece of a much larger project that the organization is implementing and was an efficient 
way to keep the momentum moving forward when there were unexpected obstacles impeding 
progress.   
The interdisciplinary coordination and collaboration between hospital oncology nurses, 
oncology clinic nurses, and home care nurses during this project provided an excellent learning 
opportunity for each professional group. It was important that patient education be consistent 
throughout the continuum of care and that all nurses follow the same hazardous drug precautions 
in every patient encounter, no matter the site.  Moreover, the project demonstrated a need for 
greater understanding of the complexities of HD administration in the home and the need to 
provide training and education to reduce risk from exposure to hazardous drug residues. 
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Appendix A 
Nurse Questionnaire Responses 
61 nurses participated in the survey at the Annual Skills Day and Competency Fair at the 
Sacramento Homecare Branch.   
Question 1: (Knowledge of the hazard) 
1. Do you think that oral chemotherapy/hazardous drug administration (HDs) is safer than 
 intravenous (IV) administration of chemotherapy/HDs for nurses in the home? 
A. Yes, oral chemotherapy administration is safer than intravenous (IV) chemotherapy 
administration for nurses in the home. (25%) 
B. No, I think oral chemotherapy administration is just as unsafe as IV chemotherapy. 
(39%) 
C. I don’t know which method of administration is safer for nurses in the home. (36% 
Response: 15 nurses answered “A”. 24 nurses answered “B”. 22 nurses answered “C”. The 
majority of nurses know that oral chemotherapy is as unsafe as IV administration in the home, 
but they don’t know which method would be safer. (Actually, both routes require the same safe-
handling requirements to protect themselves, patients and families, and the environment. 
Although it may be simpler to administer oral chemotherapy, personal protection considerations 
are warranted). 
Question 2: (Perceived Risk) 
2. How likely are you to be exposed to someone in the home receiving oral or IV 
chemotherapy? 
A. Never (3%) 
B. Unlikely (30%) 
C. Likely (16%) 
D. Highly Likely (51%) 
Response:  2 nurses answered “A”, 18 nurses answered “B”. 31 nurses answered “C”, and 10 
nurses answered “D”. (Nurses perceptions are that it is likely that someone in the home could be 
receiving or IV chemo and that they could be potentially exposed in the home setting. 
Widespread contamination of HD residues in the home have been well-documented inside the 
patient homes who receive chemotherapy or other non-oncology hazardous drugs through 
environmental contamination, although oral chemotherapy contamination is less understood). 
Question 3: (Workplace safety climate) 
3. Do you know where to find information at work about hazardous drug precautions? 
A. Yes (79%) 
B. No (21%) 
Response:  48 nurses answered “Yes”. 13 nurses answered “No”. (The organization does not 
have a policy in place for hazardous drug precautions, but nurses have been informed on where 
to find such policies in the past. A new policy is being created now for oral chemotherapy 
administration in the home setting, and a Hazardous Drug Management program will be rolled-
out to address the issues). 
Question 4: (Interpersonal influence) 
4. When you do a medication reconciliation, do you ask patients/family members if they are 
taking any chemotherapy/HD via oral, IV, topical, subcutaneous or g-tube routes? 
A. Never (16%) 
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B. Sometimes (36%) 
C. Always (43%) 
D. I don’t feel like this question is important to my role in home care. (5%) 
Response:  10 nurses answered “A”. 22 nurses answered “B”. 26 nurses answered “C”. 3 nurses 
answered “D”.  (The Electronic Health Record (HomeCare/HomeBase (HCHB) does not prompt 
the nurse to ask questions pertaining to chemotherapy/HD medication and does not alert nurses 
who enter these drugs in the patient’s medication record. Efforts are underway with the help of 
the HCHB team and the Informatics team to address these problems). 
Question 5: (Perceived conflict of interest) 
5. How comfortable are you with using a hazardous drug spill kit? 
A. Uncomfortable (17%) 
B. Comfortable (8%) 
C. I have never had the opportunity to demonstrate competency with a hazardous drug 
spill kit.  (75%) 
Response:  10 nurses answered “A”. 5 nurses answered “B”. 46 nurses answered “C”.  (This 
finding creates an opportunity to teach nurses how to properly apply PPE to prevent personal and 
environmental exposure. In addition, a new oral chemotherapy administration kit is being 
considered for inclusion into the homecare nurses’ car stock). 
 
Question 6: (Knowledge of the hazard) 
6. How familiar are you with the steps involved in managing a chemotherapy exposure in 
the home setting? 
A. Not familiar (66%) 
B. Familiar (18%) 
C. I don’t think I would ever need to manage a chemotherapy exposure in the home 
setting. (16%) 
Response:  40 nurses answered “A”. 11 nurses answered “B”. 10 nurses answered “C”. (Again, 
this is an opportunity to educate nurses on the steps required to manage a hazardous drug 
exposure, including; safe handling, containment, storage and waste disposal of contaminated 
surfaces, and reporting process). 
 
Question 7: (Self-efficacy) 
7. I am familiar with the NIOSH List of antineoplastic and other hazardous drugs (2016) 
reference tool. 
A. No (51%) 
B. Yes (19%) 
C. I have no idea what the list is or how it relates to my role in the home. (29%) 
Response:  31 nurses answered “A”. 12 nurses answered “B”. 18 nurses answered “C”. (The 
NIOSH list has the most recent hazardous drug list and the required personal protective 
equipment required to protect healthcare workers. This list may be added to the homecare nurses’ 
tablet for quick reference). 
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Home Visit #1 
Patient Information: 69 y/o male with history of acute on chronic respiratory failure due to 
recurrent aspiration pneumonia (pseudomonas), malnutrition with tube feeding, history of non-
Hodgkin’s lymphoma in 2001, head and neck cancer with dysphagia requiring PEG tube feeding, 
CAD with stroke, chronic stridor, advanced lung cancer, admitted to homecare services with IV 
needs (Zosyn 4.5grams every 6 hours via CADD SOLIS infusion pump for 5 days). 
Assessment:  CNL student, also an Oncology Certified Nurse (OCN), assisted home RN with 
medication review and noted that patient was taking an oral antineoplastic medication daily 
(Tagrisso/Osimertinib) for the treatment of advanced lung cancer.   Patient’s wife stated that she 
was dissolving the tablet in a small cup and pouring the liquid into a 60 mL syringe to drain into 
the PEG tube. Patient has chronic diarrhea, and the linens were visibly soiled. RN notified the 
MD office that patient was unable to swallow and was ingesting the medication via PEG and had 
diarrhea, which may a side effect of the oral chemotherapy drug.  The CNL student informed the 
physician that the medication should be administered via a closed-system transfer device that fits 
into the PEG tube but these are not available outside of a hospital setting. The physician did not 
suggest an alternative route for safe drug delivery. The CNL student called the Astra Zeneca 
Pharmaceutical Company (manufacturer of Tagrisso) to inquire about alternative routes and PPE 
requirements with administration. We were instructed to consult our own organization’s policy 
for hazardous oral drug administration. The patient’s wife did not have any PPE, including 
gloves, for safe handling. Home nurse was not able to provide any instructions about safe 
handling and did not have proper PPE to prevent personal exposure. The CNL spent some time 
educating the patient’s wife and provided her with several options for self-protection, such as 
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gloves, zip-lock bags, and plastic-backed barriers to reduce personal and environmental 
contamination. 
Outcome:  The CNL student called a meeting with the Sutter Health Oncology Nurse Chapter 
(SHON) to share concerns about home administration by untrained caregivers. Several oncology 
nurse practitioners and one oncology pharmacist agreed to help push the agenda forward with the 
organization. The CNL student also suggested to Astra Zeneca that they place hazardous drug 
precautions on their website for patients and families to reference, and remove the statement that 
allows the medication to be dissolved in water at home. The rationale given by the manufacturer 
was that if the medication were aerosolized with crushing, it may pose a greater danger than 
allowing it to dissolve in the water. More needs to be done to ensure safe handling of these HD 
agents in the home. 
Home Visit #2 
Patient Information:  83 y/o female with history of colon cancer with mets to the liver and 
lungs. Has ileostomy with generous output/primary caregiver is spouse. Currently receiving TPN 
for failure to thrive and ostomy output issues. 
Assessment:  Joint visit with RN to perform medication reconciliation and provide spouse with 
information on the safe handling of Megace. Spouse has been administering this medication 
without gloves or other PPE and does not feel the need to start doing it now. He has filled a cup 
with the medication at the bedside and has her sip on it every 6 hours.  Patient has dementia and 
is unable to follow commands but spouse wants to try everything to keep her comfortable.   
Outcome:  RN notified the office of the potential risks and contamination of the home 
environment to this toxic medication and asked patient’s spouse to wear gloves. Information left 
for spouse to consider regarding safe storage, administration, and waste disposal. 
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Appendix C 
SWOT ANALYSIS 
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Appendix D 
USP <800> Requirements 
 
Hazardous Drug 
Reference List 
 
 
 
Training 
 
 
 
Hazardous Drug 
Communication Program 
Requirement: 
 
Create a facility-
specific list of 
hazardous drugs that is 
accessible by all staff 
(i.e. NIOSH list of 
antineoplastic and 
other hazardous drugs, 
2016). 
 
List must be: 
1. Reviewed annually. 
2. Updated when 
newly approved 
hazardous drugs are 
incorporated into 
the practice setting. 
 
 
 
 
 
 
 
 
 
 
 
 
 
           Requirement: 
 
Training must be 
provided to all staff 
who may have contact 
with hazardous drugs 
prior to initial work 
assignment, and 
annually, thereafter. 
1. Summary of 
policies and 
procedures. 
2. Proper use of PPE 
and other 
equipment. 
3. Exposure response. 
4. Managing 
exposures. 
5. Disposal of bags, 
tubing, syringes, 
and PPE. 
6. Include oral 
chemotherapy 
medication 
administration, 
monitoring, 
procurement, and 
waste disposal. 
 
 
 
Requirement: 
 
1. Establish policies and 
procedures to ensure 
worker safety. 
2. Describe in writing 
how the standard will 
be implemented. 
3. Provide training for all 
personnel who may be 
exposed to hazardous 
drugs prior to handling. 
4. Obtain written 
confirmation that all 
personnel of 
reproductive capability 
(includes men and 
women of childbearing 
age), and understand 
the risks associated 
with hazardous drugs. 
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Appendix	E	
Budget Estimates for Project Implementation 
Two Year Projections 2017-2019 Year 1 Year 2 
Oncology Clinical Nurse Leader 1.0 FTE for 12 
months 
$90,000 0 
Health Stream Education Module Development and 
update revisions 
$1500 $1500 
Staff nurse training/competency testing @ $50.00 
per individual x 15 nurses (Home Infusion Team 
Champions) 
$750 $750 
Staff In-service- Hazardous Drug Management in the 
Home/ 15 Home Infusion Team Champions 
$750 $750 
Hazardous Drug Administration and Spill Kits ($30 
+ $16 each, respectively for RN car stock) 
$108,790 $108,790 
Staff replacement during training (rule: 1 staff in 
training = 1 less patient /visit=1 hour of service 
$750 $750 
NIOSH List of antineoplastic and other hazardous 
drugs 2016 reference guide for clinicians 
Free Free 
   
 $202,540 $112,540 
 
Cost Benefit Analysis compared to Worker’s Compensation Claims in California 2017 
 
Potential Worker’s Compensation Claims for HD Exposure 
for 10 nurses @ $37,054 per year 
 
 
$370,540 
 
 
$370,540 
Cost of HD management start-up for 15 nurses in homecare 
 
$202,540 
 
$112,540 
Cost Savings due to reducing risk of exposure 
 
$168,000 
 
$258,000 
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Appendix F 
Implementation of Kotter’s 8-Step Change Model 
   Step 1- Establish a sense of urgency/ Why change now? 
 
Hold convincing conversations about the rising trends in home chemotherapy administration. 
Share credible research data on home environmental exposure studies within the last 5 years. 
Regulatory enforcement is required by December 1, 2019 through USP <800> standards. 
Step 2- Form a powerful guiding coalition/ Who really cares? 
Seek out directors of the organizations (i.e. Chief Nursing Executive, Licensure/Accreditation, 
Education, Risk Management/Safety, Quality Management, Informatics, Nursing Team Leaders in 
Home Health, Infusion, Hospice, Palliative Care programs. 
Recruit staff that are invested in the health outcomes of patients and staff.  
Step 3- Create a vision and a Strategy/ How do we get there? 
Education modules regarding hazardous drug precautions, oral chemo administration at hire, annually. 
Staff training on use of PPE, waste disposal, and reporting exposure in the home 
 
Step 4- Communicate the vision of change/How do we share what we know? 
Regular safety meetings (quarterly), placing reference tools in Clinical Connect Employee newsletter, 
senior leadership push to get the word out in their meetings, email strategies 
Step 5- Empower others to act on a vision/ What do we do? 
Share ideas throughout the implementation process, and post communication/ideas on boards. 
Step 6- Plan for and create short-term wins/ How do we reward successes? 
Acknowledgement by senior leadership for great ideas. 
Provide CEU’s for learning modules. 
Step 7- Consolidate improvement plans and produce more change/How do we work together? 
Use SMART objectives to address gaps and barriers, and implement strategies for improvement. 
Step 8- Institutionalize new approaches in the culture/ Make it a culture of safety. 
Mandatory learning modules at hire, and annually. PPE competencies for all healthcare workers. 
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Appendix G 
GANTT CHART 
Project starts: 
01/15/2018 
Projects Ends: 
04/06/2018 
January 
2018 
Feb 
2018 
Mar 
2018 
Apr 
2018 
May 
2018 
June 
2018 
1. Annual 
Competency 
Fair Surveys 
 
15th+ 16th 
     
2. Learning 
Module/Health 
Literacy 
Tool/PPE 
Guide 
Development 
 
20th to 
 
25th 
    
3. RN in-service 
½ nursing staff 
  3rd    
4. Home Visit 
with RN 
  6th    
5. RN in-service 
½ nursing staff 
  15th    
6. Home Visit 
with RN 
  18th    
7. Share results 
with 
nurses/Post 2nd 
survey results 
  30th    
8. Share results 
with 
Leadership 
    
6th 
  
 
Persons Responsible for tasks (CNL +): 
1. Director of Education and Nursing Quality               5.  Team Leader #2/Homecare RNs 
2. Oncology Nurse Committee/Health Literacy Team   6.  Homecare RN 
3. Team Leader #1/Homecare RNs                                 7.  All Nurses and Team Leaders 
4. Homecare RN                                                              8.  All Directors                  
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Appendix H 
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Appendix I 
Quick PPE Choice Guide for Clinicians 
 
How to Report a Hazardous Spill or Occupational Exposure 
Notify your supervisor, and complete “Electronic Report of Injury” form located on the SCAH Employee Portal.  
Employee Health will contact you for follow-up. 
Running Head: HAZARDOUS DRUG ADMINISTRATION 
 
37 
Appendix J 
Hierarchy of Controls 
 
